Cutia Therapeutics 2487.HK
2487.HK
Cutia Therapeutics 2181.HK
Mabpharm Limited 2179.HK
Jiangsu Recbio Technology Co., Ltd. 2511.HK
HighTide Therapeutics Inc 1521.HK
Frontage Holdings Corporation 6978.HK
Immunotech Biopharm Ltd 6622.HK
Zhaoke Ophthalmology Limited 1061.HK
Essex Bio-Technology Limited 3681.HK
SinoMab BioScience Limited 6628.HK
Transcenta Holding Limited
Cutia Therapeutics 2181.HK
Mabpharm Limited 2179.HK
Jiangsu Recbio Technology Co., Ltd. 2511.HK
HighTide Therapeutics Inc 1521.HK
Frontage Holdings Corporation 6978.HK
Immunotech Biopharm Ltd 6622.HK
Zhaoke Ophthalmology Limited 1061.HK
Essex Bio-Technology Limited 3681.HK
SinoMab BioScience Limited 6628.HK
Transcenta Holding Limited
Performance
| Periode | 2487.HK | 2181.HK | 2179.HK | 2511.HK | 1521.HK | 6978.HK | 6622.HK | 1061.HK | 3681.HK | 6628.HK |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 71.05 % | 37.50 % | -2.13 % | 137.80 % | -6.72 % | -19.33 % | 98.06 % | 12.01 % | 32.79 % | 178.69 % |
| YTD | 29.55 % | 135.71 % | -26.26 % | 248.21 % | -34.32 % | 52.25 % | 141.73 % | 59.79 % | 48.62 % | 466.67 % |
| 1Y | -30.58 % | 83.33 % | -20.00 % | 264.49 % | 91.38 % | 74.23 % | 137.98 % | 69.26 % | 19.12 % | 233.33 % |
| 3Y | -62.05 % | 57.14 % | -72.48 % | -68.50 % | -37.64 % | -26.84 % | 34.06 % | 39.33 % | -10.99 % | -15.42 % |
| 5Y | -62.05 % | -45.45 % | -72.75 % | -68.50 % | -69.92 % | -66.20 % | -78.56 % | 4.58 % | -50.00 % | -74.32 % |
| 10Y | -62.05 % | -45.45 % | -72.75 % | -68.50 % | -66.87 % | -78.17 % | -78.56 % | -5.77 % | -73.00 % | -74.32 % |
| From the beginning | -62.05 % | -45.45 % | -72.75 % | -68.50 % | -66.87 % | -78.17 % | -78.56 % | 366.33 % | -73.00 % | -74.32 % |